Wistar Institute

Dec 19, 2019

Rafael Holdings Launches Cancer Drug Development Initiative

Dec 03, 2019

Boston Biomedical, Inc. Enters into an Alliance in Oncology Research with Columbia University, Harvard University and The Wistar Institute

Sep 26, 2019

Integral Molecular Selected as the First Industry Partner in The Wistar Institute's Biomedical Research Technician Apprenticeship

Feb 21, 2019

Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies

Feb 21, 2019

Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.

Jan 24, 2019

Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance

Jan 07, 2019

Inovio's DNA-Encoded Monoclonal Antibody (dMAb(TM)) Platform Leaps Forward with First-in-Human Trial

Sep 26, 2018

Virion Therapeutics, LLC Raises $5 Million to Develop Checkpoint Inhibitor Powered Vaccine Therapies for Treatment of Virally Induced Infectious Diseases & Cancers

May 30, 2018

Wistar Receives Grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy to Support the Breast Cancer Research Consortium

Nov 14, 2017

ITUS Corporation Licenses CAR-T Technology from The Wistar Institute